GOT TESTOSTERONE?

Serial Number 88004126
Registration 5858481
702

Registration Progress

Application Filed
Jun 18, 2018
Under Examination
Feb 5, 2019
Approved for Publication
Dec 11, 2018
Published for Opposition
Dec 11, 2018
Registered
Sep 10, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-09-10)
Due: Sep 10, 2025 38 days

Trademark Image

GOT TESTOSTERONE?

Basic Information

Serial Number
88004126
Registration Number
5858481
Filing Date
June 18, 2018
Registration Date
September 10, 2019
Published for Opposition
December 11, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Mar 5, 2025
Registration
Registered
Classes
009 016

Rights Holder

BioBalance Health, L.L.C.

16
Address
10800 Olive Blvd.
Attn. Dr. Maupin - Refer Notice to DJD
St. Louis, MO 63141

Ownership History

BioBalance Health, L.L.C.

Original Applicant
16
St. Louis, MO

BioBalance Health, L.L.C.

Owner at Publication
16
St. Louis, MO

BioBalance Health, L.L.C.

Original Registrant
16
St. Louis, MO

Legal Representation

Attorney
Dennis JM Donahue III

USPTO Deadlines

Next Deadline
38 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-09-10)
Due Date
September 10, 2025
Grace Period Ends
March 10, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Mar 5, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Mar 5, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Mar 5, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 1, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 8, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 8, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 8, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 10, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Sep 10, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 8, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 7, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 17, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 17, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 14, 2019 IUAF S USE AMENDMENT FILED Loading...
Jul 14, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 14, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 14, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 5, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 11, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 11, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 21, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 2, 2018 ALIE A ASSIGNED TO LIE Loading...
Oct 19, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 9, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 9, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 9, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 9, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 4, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 22, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 21, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 009
Downloadable e-books in the field of hormone replacement therapy; E-books featuring hormone replacement therapy recorded on computer media
First Use Anywhere: Mar 6, 2019
First Use in Commerce: Mar 6, 2019
Class 016
Books in the field of hormone replacement therapy [ ; Printed instructional, educational, and teaching materials in the field of hormone replacement therapy]
First Use Anywhere: Oct 29, 2018
First Use in Commerce: Mar 1, 2019

Classification

International Classes
009 016

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TESTOSTERONE"